Rozenbaum W - Search Results

1

The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults.

Raffi F, Reliquet V, Ferré V, Arvieux C, Hascoet C, Bellein V, Besnier JM, Breux JP, Garré M, May T, Molina JM, Perré P, Raguin G, Rozenbaum W, Zucman D. Raffi F, et al. Among authors: rozenbaum w. Antivir Ther. 2000 Dec;5(4):267-72. Antivir Ther. 2000. PMID: 11142621 Clinical Trial.

2

Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.

Reliquet V, Ferré V, Hascoet C, Besnier JM, Bellein V, Arvieux C, Molina JM, Breux JP, Zucman D, Rozenbaum W, Allavena C, Raffi F; VIRGO Study Team. Reliquet V, et al. Among authors: rozenbaum w. Antivir Ther. 1999;4 Suppl 3:83-4. Antivir Ther. 1999. PMID: 16021876 Clinical Trial.

3

Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team.

Raffi F, Reliquet V, Francois C, Garre M, Hascoet C, Allavena C, Arvieux C, Breux JP, Perre P, Rozenbaum W, Auger S. Raffi F, et al. Among authors: rozenbaum w. Antivir Ther. 1998;3 Suppl 4:57-60. Antivir Ther. 1998. PMID: 10723512 Clinical Trial.

4

Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).

Slama L, Lanoy E, Valantin MA, Bastard JP, Chermak A, Boutekatjirt A, William-Faltaos D, Billaud E, Molina JM, Capeau J, Costagliola D, Rozenbaum W. Slama L, et al. Among authors: rozenbaum w. Antivir Ther. 2008;13(1):67-76. Antivir Ther. 2008. PMID: 18389900 Clinical Trial.

5

Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).

Gallien S, Journot V, Rozenbaum W, Yéni P, Morlat P, Poizot-Martin I, Reynes J, Reliquet V, Leclercq P, Simon F, Chêne G, Molina JM; ALIZE (ANRS 099) Study Group. Gallien S, et al. Among authors: rozenbaum w. J Antimicrob Chemother. 2011 Jan;66(1):184-91. doi: 10.1093/jac/dkq395. Epub 2010 Oct 28. J Antimicrob Chemother. 2011. PMID: 21036772 Clinical Trial.

6

Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort study.

Gazaignes S, Resche-Rigon M, Gatey C, Yang C, Denis B, Fonsart J, Desseaux K, Guionie M, Rozenbaum W, Delaugerre C, Molina JM. Gazaignes S, et al. Among authors: rozenbaum w. Antivir Ther. 2016;21(4):329-36. doi: 10.3851/IMP3010. Epub 2015 Nov 13. Antivir Ther. 2016. PMID: 26566057

7

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients.

Molina JM, Ferchal F, Rancinan C, Raffi F, Rozenbaum W, Sereni D, Morlat P, Journot V, Decazes JM, Chêne G. Molina JM, et al. Among authors: rozenbaum w. J Infect Dis. 2000 Aug;182(2):599-602. doi: 10.1086/315711. Epub 2000 Jul 13. J Infect Dis. 2000. PMID: 10915095 Clinical Trial.

8

Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment.

Rozenbaum W, Katlama C, Massip P, Bentata M, Zucman D, Delfraissy JF, Trepo C, David F, Lanier ER, Vavro C, Mamet JP. Rozenbaum W, et al. Antivir Ther. 2001 Jun;6(2):135-42. Antivir Ther. 2001. PMID: 11491418 Clinical Trial.

9

Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial).

Molina JM, Peytavin G, Perusat S, Lascoux-Combes C, Sereni D, Rozenbaum W, Chene G. Molina JM, et al. Among authors: rozenbaum w. HIV Med. 2004 Mar;5(2):99-104. doi: 10.1111/j.1468-1293.2004.00194.x. HIV Med. 2004. PMID: 15012649 Free article. Clinical Trial.

10

Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).

Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P; S 130 Apollo Trial Group. Joly V, et al. Antimicrob Agents Chemother. 2013 Feb;57(2):758-65. doi: 10.1128/AAC.01662-12. Epub 2012 Nov 19. Antimicrob Agents Chemother. 2013. PMID: 23165467 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page